Article Details

Theravance Biopharma (NASDAQ:TBPH) Upgraded by Zacks Investment Research to Hold

Retrieved on: 2020-12-09 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma (NASDAQ:TBPH) Upgraded by Zacks Investment Research to Hold. View article details on hiswai:

Excerpt

Theravance <b>Biopharma</b> (NASDAQ:TBPH) last issued its quarterly earnings results on Thursday, November 5th. The <b>biopharmaceutical</b> company ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo